98 related articles for article (PubMed ID: 24706695)
41. Toward a physiological approach to breast cancer prevention.
Russo J; Russo IH
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):353-64. PubMed ID: 8061586
[TBL] [Abstract][Full Text] [Related]
42. [Relationship between structure and function of alpha-fetoprotein: conformational status and biological activity].
Moldogazieva NT; Terent'ev AA; Shaĭtan KV
Biomed Khim; 2005; 51(2):127-51. PubMed ID: 15945348
[TBL] [Abstract][Full Text] [Related]
43. Maternal levels of alpha-fetoprotein in African women.
Rogo KO; Onyango GK; Ojwang PJ; Sekkade-Kigondu C
East Afr Med J; 1991 Aug; 68(8):601-5. PubMed ID: 1722453
[TBL] [Abstract][Full Text] [Related]
44. Beyond the twinning effect: invited commentary on "Levels of maternal serum alpha-fetoprotein (AFP) in pregnant women and subsequent breast cancer risk".
Thompson WD
Am J Epidemiol; 1998 Oct; 148(8):728-9; discussion 730-1. PubMed ID: 9786227
[No Abstract] [Full Text] [Related]
45. A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptides.
Butterfield LH; Ribas A; Dissette VB; Lee Y; Yang JQ; De la Rocha P; Duran SD; Hernandez J; Seja E; Potter DM; McBride WH; Finn R; Glaspy JA; Economou JS
Clin Cancer Res; 2006 May; 12(9):2817-25. PubMed ID: 16675576
[TBL] [Abstract][Full Text] [Related]
46. The receptor binding fragment of alpha-fetoprotein is a promising new vector for the selective delivery of antineoplastic agents.
Posypanova GA; Makarov VA; Savvateeva MV; Bereznikova AV; Severin ES
J Drug Target; 2013 May; 21(5):458-65. PubMed ID: 23600748
[TBL] [Abstract][Full Text] [Related]
47. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
Ashwood ER; Cheng E; Luthy DA
Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476
[TBL] [Abstract][Full Text] [Related]
48. Obesity and insulin resistance in breast cancer--chemoprevention strategies with a focus on metformin.
Goodwin PJ; Stambolic V
Breast; 2011 Oct; 20 Suppl 3():S31-5. PubMed ID: 22015290
[TBL] [Abstract][Full Text] [Related]
49. Chemoprevention of breast cancer.
Dalton RR; Kallab AM
South Med J; 2001 Jan; 94(1):7-15. PubMed ID: 11213947
[TBL] [Abstract][Full Text] [Related]
50. Studies on a growth-inhibitory peptide derived from alpha-fetoprotein and some analogs.
Eisele LE; Mesfin FB; Bennett JA; Andersen TT; Jacobson HI; Soldwedel H; MacColl R; Mizejewski GJ
J Pept Res; 2001 Jan; 57(1):29-38. PubMed ID: 11168886
[TBL] [Abstract][Full Text] [Related]
51. [Lymphocyte apoptosis enhancement by the synthetic peptide of human alpha-fetoprotein (AFP 14-20) in experimental ulcer].
Terent'ev AA; Kazimirskiĭ AN; Lychkova AÉ; Salmasi ZhM
Eksp Klin Gastroenterol; 2014; (10):50-2. PubMed ID: 25911931
[TBL] [Abstract][Full Text] [Related]
52. Computational design and experimental discovery of an antiestrogenic peptide derived from alpha-fetoprotein.
Kirschner KN; Lexa KW; Salisburg AM; Alser KA; Joseph L; Andersen TT; Bennett JA; Jacobson HI; Shields GC
J Am Chem Soc; 2007 May; 129(19):6263-8. PubMed ID: 17441722
[TBL] [Abstract][Full Text] [Related]
53. Hemorphin as a prognostic biomarker and potential drug for breast cancer?
Song CZ; Wang QW; Song CC
Int J Cancer; 2012 Aug; 131(4):1011-2. PubMed ID: 21953447
[No Abstract] [Full Text] [Related]
54. Proof-of-Concept Study of an Alpha-Fetoprotein-Derived Peptide for the Management of Canine Mammary Cancer.
Bennett JA; Hohenhaus A; Andersen TT
Animals (Basel); 2023 Jan; 13(3):. PubMed ID: 36766292
[TBL] [Abstract][Full Text] [Related]
55. Chemoprevention of breast cancer.
Atiba JO; Meyskens FL
Semin Oncol; 1992 Jun; 19(3):220-9. PubMed ID: 1609290
[No Abstract] [Full Text] [Related]
56. Therapeutic use of human alpha-fetoprotein in clinical patients: is a cancer risk involved?
Mizejewski GJ
Int J Cancer; 2011 Jan; 128(1):239-42. PubMed ID: 20201096
[No Abstract] [Full Text] [Related]
57. Preventing cancer: are we getting closer? A breast cancer drug raises hope for chemoprevention.
Harv Health Lett; 2011 Aug; 36(10):2. PubMed ID: 27024200
[No Abstract] [Full Text] [Related]
58. High-throughput Strategy Accelerates the Progress of Marine Anticancer Peptide Drug Development.
Lyu P; Kwok HF
Recent Pat Anticancer Drug Discov; 2019; 14(1):2-4. PubMed ID: 30474536
[No Abstract] [Full Text] [Related]
59. Strategy for chemoprevention of human breast cancer.
Meyskens FL
Cancer Invest; 1988; 6(5):609-13. PubMed ID: 3214764
[No Abstract] [Full Text] [Related]
60. Cancer chemoprevention.
Amin A; Filipič M; Chen SS; Schneider-Stock R
J Biomed Biotechnol; 2012; 2012():250491. PubMed ID: 23049241
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
